Shares in Alligator Energy (ASX:AGE) jumped sharply after the company announced key progress at its Samphire uranium project in South Australia, including the launch of a field recovery trial and advancing mining lease approvals, setting the stage for a bankable feasibility study targeted for early 2027.
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
Minerals 260 (ASX:MI6) has significantly upgraded the resource estimate at its Bullabulling gold project to 4.5 million ounces, bolstered by strong drilling results and a solid cash position. The expansion shifts focus to the upcoming pre-feasibility study and execution risks as the company targets key development decisions by 2026.
Consulting giants McKinsey and BCG are integrating proprietary AI chatbots like Lilli and Casey into their famed interview processes, testing candidates on problem-solving with ambiguous, AI-generated data and shifting the skills required for the next generation of consultants.
Minerals 260 (ASX:MI6) has significantly upgraded the resource estimate at its flagship Bullabulling gold project to 4.5 million ounces, sparking renewed investor interest. Despite recent share price volatility, the long-term outlook appears buoyed by upcoming study milestones and a substantial intrinsic value gap, raising questions about whether the market is undervaluing its potential.
As Diebold Nixdorf accelerates its AI-driven self-checkout initiatives, highlighted by a new study on the Australian retail market, investors are weighing whether this technological pivot can solidify its ongoing operational turnaround and justify its current valuation.
Former Meta senior engineer Igor Tsvetkov reveals the intense pressure and bureaucratic hurdles he faced when attempting to step down from a high-stress role, ultimately leading to his return to Google—a case study in the hidden challenges of senior-level career mobility.
Integra Resources Corp. has reported its 2025 operational results from the Florida Canyon Mine, with annual production reaching 70,927 ounces of gold. While the figures confirm the mine's established scale, analysts suggest the real investment narrative hinges on the development of the larger DeLamar project and ongoing financial metrics.
Amid soaring demand for critical minerals, Ivanhoe Electric Inc. is advancing its flagship Arizona copper project while commercializing its unique Typhoon geophysical survey system, positioning the company at the intersection of resource development and technology.
Silvercorp Metals has solidified its expansion into Central Asia by acquiring a majority stake in Chaarat ZAAV CJSC, forming a joint venture with state-owned Kyrgyzaltyn to develop permitted gold projects. The move signals a strategic pivot for the historically silver-focused miner as it seeks to balance geographic and commodity risks.
Former President Trump claims tariff revenue can fund direct payments to Americans, bypassing Congress. Experts question the legality and economic feasibility of the proposal.
QatarEnergy awards McDermott a pivotal contract to plan the removal of 27 aging offshore platforms, marking the nation's first major step in responsibly retiring legacy oil and gas infrastructure.
The finalized merger between Cincinnati-based Fifth Third and Dallas's Comerica creates a banking giant with nearly $300 billion in assets, dramatically expanding its footprint in the nation's fastest-growing markets.
Investors in lighting specialist FW Thorpe have seen a negative total shareholder return of 25% since 2021, starkly underperforming the broader market's gains. Despite steady revenue growth, the share price decline highlights a disconnect with company fundamentals.
Despite a robust 57% return over three years, a deep dive into Warby Parker's financials reveals a significant disconnect between its current share price and intrinsic value estimates, raising questions about its growth trajectory justifying the premium.
Eastern Bankshares (EBC) has delivered impressive multi-year returns for shareholders, but a closer look reveals a complex valuation picture. While one model suggests deep undervaluation, traditional metrics paint a different story, leaving investors to weigh competing signals.
A pervasive culture of silence around estate planning is setting the stage for confusion and conflict as trillions in assets prepare to change hands. Experts warn that avoiding 'the talk' is a disservice to both generations.
Sanofi reports a pivotal Phase 3 win for its investigational therapy venglustat in a rare neurological disorder, alongside positive EU regulatory news for Rezurock and progress for amlitelimab, signaling a strategic shift toward high-value specialty medicines.
Quince Therapeutics' lead candidate, eDSP, has failed to meet primary and secondary endpoints in its pivotal Phase III NEAT trial for the rare neurological disorder Ataxia-Telangiectasia (A-T), triggering a catastrophic drop in the company's share price.
If your 2026 financial goals have already lost momentum, you're not alone. Experts suggest shifting focus to specific, automated strategies and building resilient habits to secure your economic future.
